These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7483543)

  • 21. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage I-II preparations in the therapy of internal diseases].
    Grebnev AL; Miagkova LP; Kkhorshed AM
    Klin Med (Mosk); 1991 Mar; 69(3):23-7. PubMed ID: 1676772
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of M-cholinolytics and histamine H2 receptor blockaders on the acid-peptide factor in patients with peptic ulcer].
    Masevich TsG; Shastina NN
    Klin Med (Mosk); 1987 Oct; 65(10):73-6. PubMed ID: 2892966
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antagonists of the histamine H2 receptors in the stomach].
    Landa L
    Gac Med Mex; 1981 Dec; 117(12):472-4. PubMed ID: 6123460
    [No Abstract]   [Full Text] [Related]  

  • 24. [Histamine H2-receptor antagonists as new anti-ulcer agents].
    Takemoto T
    Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835
    [No Abstract]   [Full Text] [Related]  

  • 25. [A comparative evaluation of the efficacy of sucralfate and H2-histamine blockaders in treating peptic ulcer].
    Ivashkin VT; Tkachenko EI; Grinevich VB; Sultanov VK; Inozemtsev SA
    Ter Arkh; 1989; 61(8):59-62. PubMed ID: 2573963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Histamine and its role in peptic gastric diseases: the discovery of histamine-H2-receptor antagonists].
    Barth H; Lorenz W
    Acta Med Austriaca; 1978; 5(2):25-31. PubMed ID: 32719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current concepts in clinical therapeutics: peptic ulcer disease.
    Siepler JK; Mahakian K; Trudeau WT
    Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mechanism of action and therapeutic effectiveness of histamine H2 receptor blockaders in peptic ulcer].
    Glubochenko VG; Shcherbak VV
    Vrach Delo; 1985 Feb; (2):13-5. PubMed ID: 2859701
    [No Abstract]   [Full Text] [Related]  

  • 29. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
    Shamburek RD; Schubert ML
    Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacological inhibition of gastric secretion and treatment of peptic ulcer].
    Konturek SJ
    Rev Esp Enferm Apar Dig; 1978 Apr; 53(1):65-82. PubMed ID: 26940
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-ulcer drugs in antisecretory doses for "cytoprotection" in arthritic patients?
    Londong W
    Klin Wochenschr; 1986; 64 Suppl 7():32-4. PubMed ID: 2882050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases].
    Miagkova LP; Grebenev AL; Kkhorshed AM
    Klin Med (Mosk); 1991 Mar; 69(3):27-34. PubMed ID: 1676773
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacologic control of gastric acid secretion in peptic ulcer.
    Konturek SJ
    Mt Sinai J Med; 1983; 50(6):457-67. PubMed ID: 6141524
    [No Abstract]   [Full Text] [Related]  

  • 34. Histamine H2-receptor antagonists.
    Keithley JK
    Nurs Clin North Am; 1991 Jun; 26(2):361-73. PubMed ID: 1675461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the safety of drugs for the long-term treatment of peptic ulcers.
    Wormsley KG
    Gut; 1984 Dec; 25(12):1416-23. PubMed ID: 6150883
    [No Abstract]   [Full Text] [Related]  

  • 36. [Medical therapy of peptic ulcer: problems and prospects].
    Trabucchi E; Foschi D; Belloli P; Montorsi F; Marchetti V; Mariscotti C; Diamantini S
    Minerva Dietol Gastroenterol; 1989; 35(1):1-6. PubMed ID: 2566959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].
    Gostishchev VK; Evseev MA
    Khirurgiia (Mosk); 2005; (8):52-7. PubMed ID: 16091681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative studies on recurrence and relapse rate in peptic ulcer treated with various types of anti-ulcer agent; inhibitors of initiating factors causing peptic ulcer].
    Ishikawa M; Saito H; Sato J
    Nihon Rinsho; 1988 Jan; 46(1):69-78. PubMed ID: 2897486
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current aspects of the therapy of gastroduodenal peptic ulcer].
    Castro Lde P
    Rev Hosp Clin Fac Med Sao Paulo; 1983; 38(2):90-102. PubMed ID: 6139870
    [No Abstract]   [Full Text] [Related]  

  • 40. [Perspectives in the drug therapy of peptic ulcer].
    Kamada T; Sato N; Kawano S
    Nihon Rinsho; 1988 Jan; 46(1):7-11. PubMed ID: 2897487
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.